Everolimus 10mg Tablets from Canada
Everolimus is an mTOR inhibitor used as an antineoplastic for renal cell carcinoma and immunosuppressive for transplant rejection, in 10mg film-coated tablets. Classified in HTS 3004.90.92.16 for dosed immunosuppressive medicaments.
Duty Rate — Canada → United States
100%
Rate breakdown
9903.04.60100%Except as provided in heading 9903.04.61, patented pharmaceutical articles as provided for in subdivisions (c) and (d) of U.S. note 40 to this subchapter
9903.05.860%Articles provided for in subdivision (b) of U.S. note 52 to this subchapter
9903.05.900%Articles of aluminum, of steel or of copper or derivative aluminum or steel articles; passenger vehicles (sedans, sport utility vehicles, crossover utility vehicles, minivans and cargo vans) and light trucks; parts of passenger vehicles (sedans, sport utility vehicles, crossover utility vehicles, minivans and cargo vans) and light trucks; medium- and heavy-duty vehicles; parts of medium- and heavy-duty vehicles; wood products; patented pharmaceutical articles; and semiconductor articles, as provided in subdivision (f) of U.S. note 52 to this subchapter
Import Tips
• Reference Orange Book patent status to determine generic import eligibility
• Ensure moisture-proof packaging documentation for hygroscopic APIs